Trial
NCT00931255
Tacrolimus to Sirolimus Conversion for Delayed Graft Function
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Maryland, Baltimore
Collaborators
Wyeth is now a wholly owned subsidiary of Pfizer
Condition
Kidney Transplant
Intervention
Tacrolimus
Why stopped
The trial was stopped because of slow recruitment.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-03-31